<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03716830</url>
  </required_header>
  <id_info>
    <org_study_id>2018P001970</org_study_id>
    <nct_id>NCT03716830</nct_id>
  </id_info>
  <brief_title>Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation</brief_title>
  <official_title>Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, investigators will examine the brain mechanism behind the synergistic effects&#xD;
      of combining acupuncture and transcranial direct current stimulation (tDCS) treatments.&#xD;
      Specifically, chronic low back pain (cLBP) patients will be recruited and randomized to one&#xD;
      of four groups (30 per group, one month of treatment): 1) verum acupuncture + real tDCS, 2)&#xD;
      sham acupuncture + real tDCS, 3) verum acupuncture + sham tDCS, and 4) sham acupuncture +&#xD;
      sham tDCS. Investigators will study 1) the longitudinal (one-month) effects of different&#xD;
      treatments as indicated by changes in resting state functional connectivity (rsFC), cerebral&#xD;
      blood flow (CBF), clinical outcomes of low back pain, and quantitative sensory test (QST) and&#xD;
      2) the association between these changes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to one of four groups: 1) verum acupuncture + real tDCS, 2) sham acupuncture + real tDCS, 3) verum acupuncture + sham tDCS, and 4) sham acupuncture + sham tDCS.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Both participants and study staff will be blinded to the treatment group of participants. Only the licensed acupuncturist will be aware of the type of acupuncture the participant will be receiving.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Periaqueductal Gray (PAG) Resting State Functional Connectivity (rsFC) Changes</measure>
    <time_frame>Day 1 (pre-intervention); post-intervention at Week 4</time_frame>
    <description>Investigators will explore whether tDCS and acupuncture treatments evoke PAG rsFC connectivity changes. This outcome will be assessed by comparing participants' pre-treatment MRI scans to their post-treatment scans.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes as Measured by LBP Intensity Scores</measure>
    <time_frame>Day 1 (pre-intervention); post-intervention at Week 4</time_frame>
    <description>The Low Back Pain Numeric Rating Scale (LBP NRS) will be used to assess clinical outcomes. Participants will be required to rate their pain on this scale prior to the first treatment and after all treatments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Blood Flow (CBF) Differences Before and After Treatments</measure>
    <time_frame>Day 1 (pre-intervention); post-intervention at Week 4</time_frame>
    <description>Investigators will examine CBF changes before and after treatment in several pain-related brain areas. CBF data will be collected during arterial spin labeling (ASL) scans that will take place before the first treatment and after the last treatment. Images from these scans will be aggregated to an average CBF-weighted image to be used for analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Sensory Testing (QST) Differences</measure>
    <time_frame>Day 1 (pre-intervention); post-intervention at Week 4</time_frame>
    <description>Participants' QST ratings will be analyzed before and after all treatments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in rsFC of M1 and Other Networks</measure>
    <time_frame>Day 1 (pre-intervention); post-intervention at Week 4</time_frame>
    <description>Similar to the CBF measure, rSFC will be analyzed from ASL data (obtained during MRI scanning). rSFC from pre- to post-treatment will be compared.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>verum acupuncture + real tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham acupuncture + real tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>verum acupuncture + sham tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham acupuncture + sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>verum acupuncture</intervention_name>
    <description>Participants will receive real acupuncture treatment.</description>
    <arm_group_label>verum acupuncture + real tDCS</arm_group_label>
    <arm_group_label>verum acupuncture + sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham acupuncture</intervention_name>
    <description>Participants will receive sham acupuncture treatment.</description>
    <arm_group_label>sham acupuncture + real tDCS</arm_group_label>
    <arm_group_label>sham acupuncture + sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>real tDCS</intervention_name>
    <description>Participants will receive real transcranial direct current stimulation.</description>
    <arm_group_label>sham acupuncture + real tDCS</arm_group_label>
    <arm_group_label>verum acupuncture + real tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>Participants will receive sham transcranial direct current stimulation.</description>
    <arm_group_label>sham acupuncture + sham tDCS</arm_group_label>
    <arm_group_label>verum acupuncture + sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  volunteers 18-60 years of age&#xD;
&#xD;
          -  meet the classification criteria of chronic low back pain (having low back pain for&#xD;
             more than 6 months), as determined by the referring physician&#xD;
&#xD;
          -  at least 4/10 clinical pain on the 11-point Low Back Pain Numeric Rating Scale (LBP&#xD;
             NRS)&#xD;
&#xD;
          -  at least a 10th grade English-reading level; English can be a second language provided&#xD;
             that the patients understand all questions used in the assessment measures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of epilepsy or loss consciousness (LOC)&#xD;
&#xD;
          -  specific causes of back pain (e.g. cancer, fractures, spinal stenosis, infections)&#xD;
&#xD;
          -  complicated back problems (e.g. prior back surgery, medicolegal issues)&#xD;
&#xD;
          -  the intent to undergo surgery during the time of involvement in the study&#xD;
&#xD;
          -  history of cardiac, respiratory, or nervous system disease that, in the investigator's&#xD;
             judgment, precludes participation in the study because of a heightened potential for&#xD;
             adverse outcomes. For example: asthma or claustrophobia&#xD;
&#xD;
          -  presence of any contraindications to magnetic resonance imaging (MRI) scanning. For&#xD;
             example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, inability to&#xD;
             remain still in MRI scanner&#xD;
&#xD;
          -  history of medical or psychiatric illness as determined by the investigator&#xD;
&#xD;
          -  history of substance abuse or dependence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jian Kong</last_name>
    <phone>617-726-7893</phone>
    <email>jkong2@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129-2020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maya Eshel</last_name>
      <email>meshel@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Dao</last_name>
      <email>rdao@mgh.harvard.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 18, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Jian Kong</investigator_full_name>
    <investigator_title>Associate Professor, Associate Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

